Roundview Capital Boosted Celgene (CELG) Stake By $311,750; Stonerise Capital Management Has Cut Akamai Technologies (AKAM) Position

February 17, 2018 - By Richard Conner

Stonerise Capital Management Llc decreased Akamai Technologies Inc (AKAM) stake by 50% reported in 2017Q3 SEC filing. Stonerise Capital Management Llc sold 75,000 shares as Akamai Technologies Inc (AKAM)’s stock declined 24.00%. The Stonerise Capital Management Llc holds 75,000 shares with $3.65M value, down from 150,000 last quarter. Akamai Technologies Inc now has $11.32B valuation. The stock decreased 0.76% or $0.51 during the last trading session, reaching $66.89. About 1.17M shares traded. Akamai Technologies, Inc. (NASDAQ:AKAM) has declined 6.51% since February 17, 2017 and is downtrending. It has underperformed by 23.21% the S&P500.

Roundview Capital Llc increased Celgene Corp (CELG) stake by 9.56% reported in 2017Q3 SEC filing. Roundview Capital Llc acquired 2,150 shares as Celgene Corp (CELG)’s stock declined 3.49%. The Roundview Capital Llc holds 24,648 shares with $3.59 million value, up from 22,498 last quarter. Celgene Corp now has $71.65B valuation. The stock decreased 0.92% or $0.88 during the last trading session, reaching $95.26. About 5.78M shares traded. Celgene Corporation (NASDAQ:CELG) has risen 17.00% since February 17, 2017 and is uptrending. It has outperformed by 0.30% the S&P500.

Since September 5, 2017, it had 1 insider buy, and 3 sales for $2.54 million activity. $299,594 worth of Celgene Corporation (NASDAQ:CELG) shares were bought by Alles Mark J. Curran Terrie sold 1,727 shares worth $248,498. CASEY MICHAEL D also sold $1.29 million worth of Celgene Corporation (NASDAQ:CELG) shares. KAPLAN GILLA sold $1.31M worth of stock or 9,250 shares.

Roundview Capital Llc decreased Energy Select Sector Spdr (XLE) stake by 34,441 shares to 9,553 valued at $654,000 in 2017Q3. It also reduced Charles Schwab Corp Com (NYSE:SCHW) stake by 34,950 shares and now owns 36,305 shares. Caterpillar Inc (NYSE:CAT) was reduced too.

Investors sentiment decreased to 1.17 in 2017 Q3. Its down 0.17, from 1.34 in 2017Q2. It is negative, as 44 investors sold CELG shares while 457 reduced holdings. 133 funds opened positions while 451 raised stakes. 603.99 million shares or 0.25% more from 602.51 million shares in 2017Q2 were reported. Harvey Cap Mngmt owns 65,300 shares for 3.84% of their portfolio. Korea Invest, Korea-based fund reported 795,265 shares. Ray Gerald L And invested 4.62% of its portfolio in Celgene Corporation (NASDAQ:CELG). Crestwood Advsr Grp Inc Limited Liability Com, Massachusetts-based fund reported 3,791 shares. 3,604 are owned by Mckinley Carter Wealth Svcs Incorporated. Invest Advsr has 0.79% invested in Celgene Corporation (NASDAQ:CELG). 38,140 were reported by Chase Investment Counsel Corp. Moreover, Mathes has 0.14% invested in Celgene Corporation (NASDAQ:CELG). Ironwood Limited Liability Corp owns 84 shares. Nomura Asset Mngmt holds 1.35% in Celgene Corporation (NASDAQ:CELG) or 715,877 shares. Blackrock Incorporated reported 0.41% in Celgene Corporation (NASDAQ:CELG). Stralem Communication has invested 2.13% in Celgene Corporation (NASDAQ:CELG). Northeast Inv stated it has 132,757 shares or 1.71% of all its holdings. David R Rahn & Associates Incorporated invested 1.51% of its portfolio in Celgene Corporation (NASDAQ:CELG). Tdam Usa Inc reported 0.2% in Celgene Corporation (NASDAQ:CELG).

Among 33 analysts covering Celgene Corporation (NASDAQ:CELG), 19 have Buy rating, 2 Sell and 12 Hold. Therefore 58% are positive. Celgene Corporation had 132 analyst reports since July 21, 2015 according to SRatingsIntel. Mizuho initiated Celgene Corporation (NASDAQ:CELG) rating on Tuesday, November 8. Mizuho has “Buy” rating and $130 target. The stock has “Buy” rating by Oppenheimer on Thursday, July 27. Suntrust Robinson initiated the shares of CELG in report on Thursday, January 7 with “Buy” rating. As per Thursday, February 25, the company rating was initiated by Citigroup. Robert W. Baird maintained Celgene Corporation (NASDAQ:CELG) on Thursday, October 26 with “Hold” rating. The rating was maintained by Mizuho with “Buy” on Monday, February 5. BMO Capital Markets maintained Celgene Corporation (NASDAQ:CELG) rating on Thursday, October 5. BMO Capital Markets has “Buy” rating and $160.0 target. As per Tuesday, September 26, the company rating was maintained by Cantor Fitzgerald. The rating was initiated by Leerink Swann with “Market Perform” on Friday, February 5. On Thursday, July 6 the stock rating was maintained by Stifel Nicolaus with “Buy”.

Since October 2, 2017, it had 1 buy, and 5 insider sales for $3.86 million activity. MCCONNELL RICK M sold $386,529 worth of Akamai Technologies, Inc. (NASDAQ:AKAM) on Tuesday, October 10. Another trade for 17,537 shares valued at $999,784 was made by LEIGHTON F THOMSON on Friday, December 15. The insider Wheaton William sold $662,900.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:

Recent Posts